Free Trial

Benjamin Burnett Analyst Performance

Analyst at Wells Fargo & Company

Benjamin Burnett is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 28 publicly traded companies. Over the past year, Benjamin Burnett has issued 78 stock ratings, including buy and hold recommendations. While full access to Benjamin Burnett's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Benjamin Burnett's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
97 Last 7 Years
Buy Recommendations
78.13% 75 Buy Ratings
Companies Covered
28 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy2.1%2 ratings
Buy76.0%73 ratings
Hold21.9%21 ratings
Sell0.0%0 ratings

Out of 96 total stock ratings issued by Benjamin Burnett at Wells Fargo & Company, the majority (76.0%) have been Buy recommendations, followed by 21.9% Hold and 2.1% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
28 companies

Benjamin Burnett, an analyst at Wells Fargo & Company, currently covers 28 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
28 companies
100.0%

Benjamin Burnett of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
17 companies
60.7%
PHARMACEUTICALS
11 companies
39.3%

Benjamin Burnett's Ratings History at Wells Fargo & Company

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Liquidia Corporation stock logo
LQDA
Liquidia
10/2/2026Reiterated Rating$27.99$30.00Equal Weight
Liquidia Corporation stock logo
LQDA
Liquidia
10/1/2026Downgrade$28.64$30.00Equal Weight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
9/18/2026Lower Price Target$57.35$64.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
8/20/2026Boost Price Target$25.92$46.00Overweight
Liquidia Corporation stock logo
LQDA
Liquidia
8/13/2026Boost Price Target$78.79$108.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
8/13/2026Boost Price Target$72.64$109.00Overweight
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
8/13/2026Boost Price Target$42.79$72.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
8/11/2026Boost Price Target$220.89$256.00Overweight
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
8/7/2026Reiterated Rating$370.16$362.00Positive
Insmed, Inc. stock logo
INSM
Insmed
8/7/2026Boost Price Target$132.55$169.00Overweight
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
8/7/2026Boost Price Target$21.85$20.00Equal Weight
MannKind Corporation stock logo
MNKD
MannKind
8/6/2026Lower Price Target$4.10$13.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
8/5/2026Lower Price Target$25.31$45.00Overweight
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
8/4/2026Lower Price Target$10.11$18.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/31/2026Boost Price Target$75.52$106.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
7/30/2026Boost Price Target$3.85$14.00Overweight
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
7/27/2026Initiated Coverage$11.26$13.00Equal Weight
GH Research PLC stock logo
GHRS
GH Research
7/27/2026Initiated Coverage$27.28$44.00Overweight
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
7/27/2026Initiated Coverage$43.17$68.00Overweight
Cybin Inc. stock logo
HELP
Cybin
7/27/2026Initiated Coverage$7.62$16.00Overweight
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
7/27/2026Initiated Coverage$11.27$13.00Equal Weight
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
7/27/2026Initiated Coverage$42.65$68.00Overweight
GH Research PLC stock logo
GHRS
GH Research
7/27/2026Initiated Coverage$27.75$44.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
7/20/2026Lower Price Target$78.59$93.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
7/15/2026Boost Price Target$110.11$161.00Overweight
Alkermes plc stock logo
ALKS
Alkermes
6/29/2026Boost Price Target$55.08$65.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
6/1/2026Set Price Target$3.77$11.00Overweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
5/20/2026Boost Price Target$6.14$14.00Overweight
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
5/14/2026Reiterated Rating$18.32$19.00Equal Weight
Liquidia Corporation stock logo
LQDA
Liquidia
5/12/2026Boost Price Target$53.13$62.00Overweight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
5/8/2026Boost Price Target$71.29$95.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
5/8/2026Lower Price Target$104.53$160.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
5/7/2026Boost Price Target$3.56$10.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
5/7/2026Upgrade$596.76$735.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
5/6/2026Boost Price Target$25.71$47.00Overweight
Alkermes plc stock logo
ALKS
Alkermes
5/6/2026Boost Price Target$36.11$44.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
5/5/2026Boost Price Target$229.12$255.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
4/28/2026Boost Price Target$2.72$8.00Overweight
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
4/20/2026Downgrade$39.61$42.00Equal Weight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
3/31/2026Boost Price Target$590.17$575.00Equal Weight
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
3/27/2026Lower Price Target$6.20$13.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
3/23/2026Boost Price Target$531.66$486.00Equal Weight
Liquidia Corporation stock logo
LQDA
Liquidia
3/23/2026Boost Price Target$36.89$51.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
3/23/2026Lower Price Target$144.80$175.00Overweight
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
3/11/2026Boost Price Target$30.44$46.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
3/10/2026Boost Price Target$60.06$68.00Overweight
Liquidia Corporation stock logo
LQDA
Liquidia
3/6/2026Boost Price Target$34.24$44.00Overweight
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
3/5/2026Lower Price Target$12.30$20.00Overweight
Amphastar Pharmaceuticals, Inc. stock logo
AMPH
Amphastar Pharmaceuticals
2/27/2026Lower Price Target$22.57$30.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
2/27/2026Boost Price Target$43.41$49.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
2/27/2026Lower Price Target$3.28$7.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
2/26/2026Boost Price Target$503.34$466.00Equal Weight
Alkermes plc stock logo
ALKS
Alkermes
2/26/2026Boost Price Target$30.41$43.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
2/24/2026Boost Price Target$174.76$202.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
2/20/2026Lower Price Target$161.00$208.00Overweight
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/20/2026Set Price Target$331.61$305.00Equal Weight
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
2/20/2026Lower Price Target$69.90$86.00Overweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
2/12/2026Lower Price Target$12.79$27.00Overweight
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
2/2/2026Initiated Coverage$314.00$282.00Equal Weight
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
2/2/2026Initiated Coverage$26.61$43.00Overweight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
1/13/2026Boost Price Target$176.82$193.00Overweight
Ultragenyx Pharmaceutical Inc. stock logo
RARE
Ultragenyx Pharmaceutical
12/30/2025Lower Price Target$19.72$45.00Overweight
Insmed, Inc. stock logo
INSM
Insmed
12/18/2025Set Price Target$198.46$195.00
Savara Inc. stock logo
SVRA
Savara
12/18/2025Boost Price Target$6.06$9.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
12/11/2025Boost Price Target$43.85$48.00Overweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
12/9/2025Boost Price Target$18.52$29.00Overweight
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
11/20/2025Boost Price Target$23.10$22.50Equal Weight
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
11/13/2025Boost Price Target$26.07$35.00Overweight
Alkermes plc stock logo
ALKS
Alkermes
11/13/2025Lower Price Target$31.19$37.00Overweight
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
11/11/2025Lower Price Target$7.18$16.00Overweight
MannKind Corporation stock logo
MNKD
MannKind
11/11/2025Lower Price Target$5.22$8.00Overweight
Keros Therapeutics, Inc. stock logo
KROS
Keros Therapeutics
11/11/2025Lower Price Target$16.73$23.00Overweight
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
11/7/2025Lower Price Target$22.12$30.00Overweight
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
11/7/2025Boost Price Target$18.73$20.00Equal Weight
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
11/4/2025Lower Price Target$135.75$157.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
11/4/2025Reiterated Rating$41.12$44.00Overweight
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
10/30/2025Boost Price Target$452.36$423.00Equal Weight
Alkermes plc stock logo
ALKS
Alkermes
10/29/2025Lower Price Target$31.16$42.00Overweight
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
9/3/2025Initiated Coverage$17.27$31.00Overweight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
9/3/2025Initiated Coverage$39.30$48.00Overweight
Alkermes plc stock logo
ALKS
Alkermes
9/3/2025Upgrade$30.00Strong-Buy
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
9/3/2025Upgrade$14.66Hold
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
9/3/2025Upgrade$122.00Strong-Buy
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
9/2/2025Initiated Coverage$123.47$163.00Overweight
Avadel Pharmaceuticals PLC. stock logo
AVDL
Avadel Pharmaceuticals
9/2/2025Initiated Coverage$14.98$16.00Equal Weight
Alkermes plc stock logo
ALKS
Alkermes
9/2/2025Initiated Coverage$29.40$44.00Overweight
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
4/1/2025Lower Price Target$35.36$64.00Buy
Fate Therapeutics, Inc. stock logo
FATE
Fate Therapeutics
3/6/2025Lower Price Target$0.98$3.00Hold
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
2/27/2025Lower Price Target$40.94$78.00Buy
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
2/13/2025Lower Price Target$42.61$49.00Hold
Ready to give options a try? Your first trade (Ticker included) -INSIDE (Ad)

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel

Disc Medicine, Inc. stock logo
IRON
Disc Medicine
1/24/2025Boost Price Target$57.07$94.00Buy